LRMR
Larimar Therapeutics Inc
3.00$
-3.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +5.5% | +14.3% | +0.0% | -6.8% | -1.2% | -4.9% | -58.4% | +68.8% | -9.3% | +40.8% | +17.4% | -1.2% | +8.7% | -14.9% | +225.7% | -63.5% | -1.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -136.5% | – | – | – | – | – | – | |
| – | -27.3% | +33.0% | +8.8% | -7.6% | +12.2% | +13.9% | -1.8% | -3.1% | -3.2% | -100.0% | +73,988.1% | +156.8% | -32.7% | -7.4% | +77.9% | -22.3% | +52.8% | -15.1% | +1.4% | +54.1% | -55.1% | -7.7% | -2.8% | -1.1% | +29.3% | -36.8% | +28.8% | +12.1% | +60.5% | +21.7% | +53.1% | -29.3% | +92.1% | -0.7% | -12.0% | +92.3% | +32.1% | -57.8% | +11.9% | – | |
| – | -33.7% | +12.1% | -16.2% | +3.6% | -21.5% | +33.6% | +2.5% | -0.4% | -3.1% | -100.0% | +114,641.0% | +3.1% | +26.6% | +121.7% | +49.5% | +37.1% | +11.9% | -18.1% | +9.9% | -21.5% | +3.4% | +10.3% | -1.2% | -3.7% | +9.9% | -4.5% | +21.8% | +0.2% | -6.4% | +8.0% | +29.6% | -11.6% | +4.8% | +1.8% | -4.6% | +3.3% | +1.7% | +31.0% | +4.4% | – | |
| – | -29.4% | +26.6% | +2.0% | -5.1% | +4.0% | +17.5% | -0.9% | -2.5% | -3.2% | -100.0% | +78,308.1% | +132.9% | -28.6% | +8.4% | +70.8% | -9.3% | +39.3% | -15.9% | +3.6% | +33.4% | -45.7% | -2.2% | -2.3% | -2.0% | +22.6% | -26.8% | +26.0% | +7.5% | +36.2% | +18.3% | +47.7% | -25.8% | +71.3% | -0.3% | -10.9% | +78.1% | +29.3% | -51.4% | +10.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -26.5% | -24.7% | -27.4% | -41.5% | -74.2% | +5,625.0% | +1.7% | +1.9% | +5.1% | -66.9% | +189.7% | -10.9% | +353.3% | -84.4% | – | – | – | – | – | – | – | – | -64.3% | +865.0% | -59.6% | +1,324.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -2,670.3% | – | – | – | – | – | – | – | – | – | – | – | -135.7% | – | – | – | – | – | – | -1.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.